Drugs / VG290131
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06081465 | Oct 2023 → Dec 2024 overdue | — | Zhejiang Vimgreen Pharmaceuticals, Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VG290131 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06081465 ↗ |
| Route | Oral | “The study drug and matching placebo will be administered orally.” NCT06081465 ↗ |